XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Net product sales $ 29,615 $ 23,457
Operating expenses:    
Cost of product sales 16,854 11,355
Research and development 13,817 42,070
General and administrative 10,853 9,533
Sales and marketing 21,154 23,422
Total operating expenses 62,678 86,380
Loss from operations (33,063) (62,923)
Other income (expense), net 295 (965)
Net loss (32,768) (63,888)
Other comprehensive loss:    
Unrealized gains (losses) on short-term investments 28 (2)
Comprehensive loss $ (32,740) $ (63,890)
Basic net loss per share $ (0.27) $ (0.63)
Shares used in computing basic net loss per share 119,246 102,123
Diluted net loss per share $ (0.27) $ (0.63)
Shares used in computing diluted net loss per share 119,246 102,123